ATHE

Alterity Therapeutics Limited
2.67
0.14 (5.53%)

Alterity Therapeutics Limited (ATHE) Fundamentals

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
SHARE INFORMATION
Market CapUS$ 10,904,088
Shares Outstanding4,027,364
Float4,027,364
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -2.19
Latest Fiscal Date2022-06-30
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions13
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months448
Institutional Holdings Percent1.7%
Institutional Sold Previous 3 Months52,622
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 8.73
52 Week LowUS$ 2.61
52 Week High ChangeUS$ -65.08
21 Day Moving AverageUS$ 3.062
21 Day Extended Moving AverageUS$ 3.0375
50 Day Moving AverageUS$ 3.4891
50 Day Extended Moving AverageUS$ 3.3108
200 Day Moving AverageUS$ 4.6222
200 Day Extended Moving AverageUS$ 4.7399
10 Day Average Volume64,103
20 Day Average Volume35,426
30 Day Average Volume29,439
50 Day Average Volume29,767
Alpha-0.025947
Beta1.2612
Standard Deviation0.214854
R20.099933
7 Day Price ChangeUS$ 0.0975
7 Day Percent Change3.74%
21 Day Price ChangeUS$ -0.5925
21 Day Percent Change-17.95%
30 Day Price ChangeUS$ -0.4625
30 Day Percent Change-14.59%
Month to Date Price ChangeUS$ -0.5025
Month to Date Percent Change-15.65%
Quarter to Date Price ChangeUS$ -0.7745
Quarter to Date Percent Change-22.24%
180 Day Price ChangeUS$ -2.19
180 Day Percent Change-44.68%
200 Day Price ChangeUS$ -3.09
200 Day Percent Change-53.27%
Year to Date Price ChangeUS$ -0.7745
Year to Date Percent Change-22.24%

Alterity Therapeutics Limited (ATHE) Key Ratios

PROFITABILITY
EBIT Margin-157,134.3%
EBITDA Margin-156,409.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 6,718
Revenue Per ShareUS$ 0.0017
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio6.30
Leverage Ratio1.30
Quick Ratio6.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.50
Enterprise ValueUS$ -10,282,156
Price to Sales1,623.1152
Price to Free Cash-1.20
PE High Last 5 Years-1.90
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-2.70
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-36.51
Return on Equity-41.30
Return on Capital-41.30

Alterity Therapeutics Limited (ATHE) Profile

PROFILE INFO
Issue TypeAD
SEC TypeDR
AuditorPricewaterhouseCoopers
CEODavid A. Stamler
Emplyoees12
Last AuditUQ
CIK0001131343
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address460 Bourke Street
Level 3
Melbourne, VIC 3000
Websitehttps://www.alteritytherapeutics.com
Facsimile+61 398227735
Telephone+61 393494906
Emailinfo@pranabio.com
Your Recent History
NASDAQ
ATHE
Alterity T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 10:03:45